Emerging indications for octreotide therapy, Part 1.

  title={Emerging indications for octreotide therapy, Part 1.},
  author={Kristen Wilkinson Mosdell and James A. Visconti},
  journal={American journal of hospital pharmacy},
  volume={51 9},
Possible new indications for the use of octreotide are discussed. In October 1988, octreotide received FDA-approved labeling for use in the management of carcinoid syndrome and vipomas. Since that time, research results and clinical experience have accumulated that suggest a potentially much broader therapeutic role for octreotide. Reports continue to be… CONTINUE READING